New Covenant Trust Company’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$806K Buy
6,276
+241
+4% +$28.2K 0.61% 34
2026
Q1
$726K Buy
6,035
+221
+4% +$25.5K 0.65% 29
2025
Q4
$619K Buy
5,814
+48
+0.8% +$4.51K 0.56% 32
2025
Q3
$484K Sell
5,766
-62
-1% -$5.11K 0.45% 38
2025
Q2
$461K Sell
5,828
-56
-1% -$4.45K 0.41% 37
2025
Q1
$525K Sell
5,884
-315
-5% -$29.4K 0.55% 34
2024
Q4
$610K Sell
6,199
-225
-4% -$23.2K 0.61% 31
2024
Q3
$730K Buy
6,424
+441
+7% +$52.4K 0.71% 26
2024
Q2
$752K Sell
5,983
-137
-2% -$17.6K 0.87% 22
2024
Q1
$808K Buy
+6,120
New +$754K 0.81% 19

Other funds holding MRK

New Covenant Trust Company's MRK Position: Q2 2026 in Review

New Covenant Trust Company increased its Merck (MRK) stake by 4% in Q2 2026, buying an estimated $28.2K and bringing the position to 6,276 shares worth $806K. The position accounts for 0.61% of the portfolio, ranked #34.

New Covenant Trust Company first reported a position in MRK in Q1 2024 and has held it in 10 quarters since. The position peaked at $808K in Q1 2024. 1,299 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • New Covenant Trust Company held 6,276 shares of Merck worth $806K as of Q2 2026.
  • New Covenant Trust Company bought 241 Merck shares in Q2 2026, an estimated $28.2K.
  • Merck made up 0.61% of New Covenant Trust Company's portfolio in Q2 2026, its #34 holding.
  • New Covenant Trust Company first reported a position in Merck in Q1 2024 and has held it in 10 quarters since.
  • New Covenant Trust Company's Merck position peaked at $808K in Q1 2024.
  • 1,299 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on New Covenant Trust Company's 13F filing for Q2 2026, filed 14 Jul 2026.